Premenopausal Reproductive and Hormonal Characteristics and the Risk for Osteoporosis

Osteoporosis: Fourth Edition

Volumn , Issue , 2013, Pages 721-744

  Randolph, John F ^a   Sowers, MaryFran R ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anorexia nervosa; Bone mineral content (BMC); Calciotropic hormones; DMPA; Dysfunctional ovulation; Fracture; Hyperprolactinemia; Lactation; Menarche; OCPs; Oophorectomy; Osteoporosis; Parity; Polycystic ovarian syndrome (PCOS); Pregnancy; Premenopausal bone mass; PTHrP

Indexed keywords

EID: 84903076728     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415853-5.00030-3     Document Type: Chapter

References (280)

1. Mazess R.B. On aging bone loss. Clin Orthop Relat Res 1982, 165:239-252.
2. Horsman A., Burkinshaw L. Stochastic models of femoral bone loss and hip fracture risk. Clinical Disorders of Bone and Mineral Metabolism 1989, 253-263. Mary Ann Liebert, Larchmont, NY. M.J. Kleerkoper, S.M. Krane (Eds.).
3. World Health Organization Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. Technical Report Series 1994, 843.
4. Jaffe R.B., Dell'Acqua S. The Endocrine Physiology of Pregnancy and the Peripartal Period 1985, Raven Press, New York.
5. Fritz M.A., Speroff L. Clinical Reproductive Endocrinology and Infertility 2011, Lippincott Williams and Wilkins, Philadelphia.
6. Givens M.H., Macy I.G. The chemical composition of the human fetus. J Biol Chem 1933, 102:7-17.
7. Kent G.N., Price R.I., Gutteridge D.H., Allen J.R., Blakeman S.L., Bhagat C.I., et al. Acute effects of an oral calcium load in pregnancy and lactation: findings on renal calcium conservation and biochemical indices of bone turnover. Miner Electrolyte Metab 1991, 17:1-7.
8. Ritchie L.D., Fung E.B., Halloran B.P., Turnlund J.R., Van Loan M.D, et al. A longitudinal study of calcium homeostasis during human pregnancy and lactation after resumption of menses. Am J Clin Nutr 1998, 67:693-701.
9. Pedersen E.B., Johannsen P., Kristensen S., Rasmussen A.B., Emmertsen K., Moller J., et al. Calcium, parathyroid hormone and calcitonin in normal pregnancy and preeclampsia. Gynecol Obstet Invest 1984, 18:156-164.
10. Marya R.K., Rathee S., Manrow M. Urinary calcium excretion in pregnancy. Gynecol Obstet Invest 1987, 23:141-144.
11. Markestad T., Ulstein M., Aksnes L., Aarskog D. Serum concentrations of vitamin D metabolites in vitamin D supplemented pregnant women. A longitudinal study. Acta Obstet Gynecol Scand 1986, 65:63-67.
12. Pitkin R.M., Reynolds W.A., Williams G.A., Hargis G.K. Calcium metabolism in normal pregnancy: a longitudinal study. Am J Obstet Gynecol 1979, 133:781-790.
13. Kuoppala T., Tuimala R., Parviainen M., Koskinen T., Ala-Houhala M. Serum levels of vitamin D metabolites, calcium, phosphorus, magnesium and alkaline phosphatase in Finnish women throughout pregnancy and in cord serum at delivery. Hum Nutr Clin Nutr 1986, 40:287-293.
14. Duggin G.G., Dale N.E., Lyneham R.C., Evans R.A., Tiller D.J. Calcium balance in pregnancy. Lancet 1974, 2:926-927.
15. Heaney R.P., Skillman T.G. Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab 1971, 33:661-670.
16. Shenolikar I.S. Absorption of dietary calcium in pregnancy. Am J Clin Nutr 1970, 23:63-67.
17. Frisancho A.R., Garn S.M., Ascoli W. Unaltered cortical area of pregnant and lactating women. Studies of the second metacarpal bone in North and Central American populations. J Clin Endocrinol Metab 1971, 6:119-121.
18. Christiansen C., Rodbro P., Heinlid B. Unchanged total body calcium in normal human pregnancy. Acta Obstet Gynecol Scand 1976, 55:141-143.
19. Sowers M., Crutchfield M., Jannausch M., Updike S., Corton G. A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 1991, 77:841-845.
20. Kent G.N., Price R.I., Gutteridge D.H., Allen J.R., Rosman K.J., Smith M., et al. Effect of pregnancy and lactation on maternal bone mass and calcium metabolism. Osteoporos Int 1993, 3(Suppl):44-47.
21. Lamke B., Brundin J., Moberg P. Changes of bone mineral content during pregnancy and lactation. Acta Obstet Gynecol Scand 1977, 56:217-219.
22. Drinkwater B.L., Chesnut C.H. Bone density changes during pregnancy and lactation in active women: a longitudinal study. Bone Miner 1991, 14:153-160.
23. Sowers M., Jannausch M., Scholl T., Schall J. The reproducibility of ultrasound bone measures in a triethnic population of pregnant adolescents and adult women. J Bone Miner Res 1998, 13:1768-1774.
24. Aguado F., Revilla M., Hernandez E.R., Menendez M., Cortes-Prieto J., Villa L.F., et al. Ultrasonographic bone velocity in pregnancy: a longitudinal study. Am J Obstet Gynecol 1998, 178:1016-1021.
25. Sowers M.F., Scholl T., Harris L., Jannausch M. Bone loss in adolescent and adult pregnant women. Obstet Gynecol 2000, 96:189-193.
26. Gambacciani M., Spinetti A., Gallo R., Cappagli B., Teti G.C., Facchini V. Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation. Am J Obstet Gynecol 1995, 173:890-893.
27. Tranquilli A.L., Giannubilo S.R., Corradetti A. Ultrasound measurement of pregnancy-induced changes in maternal bone mass: a longitudinal, cross-sectional and biochemical study. Gynecol Endocrinol 2004, 18:258-262.
28. Yamaga A., Taga M., Minaguchi H., Sato K. Changes in bone mass as determined by ultrasound and biochemical markers of bone turnover during pregnancy and puerperium: a longitudinal study. J Clin Endocrinol Metab 1996, 81:752-756.
29. O'Brien K.O., Donangelo C.M., Zapata C.L., Abrams S.A., Spencer E.M., King J.C. Bone calcium turnover during pregnancy and lactation in women with low calcium diets is associated with calcium intake and circulating insulin-like growth factor 1 concentrations. Am J Clin Nutr 2006, 83:317-323.
30. Olausson H., Laskey M.A., Goldberg G.R., Prentice A. Changes in bone mineral status and bone size during pregnancy and the influences of body weight and calcium intake. Am J Clin Nutr 2008, 88:1032-1039.
31. Moller U.K., Vio Streym S., Mosekilde L., Rejnmark L. Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporos Int 2012, 23:1213-1223.
32. Seki K., Makimura N., Mitsui C., Hirata J., Nagata I. Calcium-regulating hormones and osteocalcin levels during pregnancy: a longitudinal study. Am J Obstet Gynecol 1991, 164:1248-1252.
33. Rodin A., Duncan A., Quartero H.W., Pistofidis G., Mashiter G., Whitaker K., et al. Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy. J Clin Endocrinol Metab 1989, 68:1123-1127.
34. Cole D.E., Gundberg C.M., Stirk L.J., Atkinson S.A., Hanley D.A., Ayer L.M., et al. Changing osteocalcin concentrations during pregnancy and lactation: implications for maternal mineral metabolism. J Clin Endocrinol Metab 1987, 65:290-294.
35. Sowers M., Scholl T., Grewal J., Chen X., Jannausch M. IGF-1, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women. J Clin Endocrinol Metab 2001, 86:5898-5903.
36. Okonofua F., Menon R.K., Houlder S., Thomas M., Robinson D., O'Brien S., et al. Calcium, vitamin D and parathyroid hormone relationships in pregnant Caucasian and Asian women and their neonates. Ann Clin Biochem 1987, 24:22-28.
37. Hellmeyer L., Ziller V., Anderer G., Ossendorf A., Schmidt S., Hadji P. Biochemical markers of bone turnover during pregnancy: a longitudinal study. Exp Clin Endocrinol Diabetes 2006, 114:506-510.
38. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001, 142:5050-5055.
39. Naylor K.E., Rodgers A., Fraser R.B., Hall V., Eastell R., Blumsohn A. Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrinol Metab 2003, 88:5361-5365.
40. Verhaeghe J., Bouillon R. Calciotropic hormones during reproduction. J Steroid Biochem Mol Biol 1992, 41:469-477.
41. Chesney R.W., Specker B.L., Mimouni F., McKay S. Mineral metabolism during pregnancy and lactation. Disorders of Bone and Mineral Metabolism 1992, 383-393. Raven Press, London. F.L. Coe, M.J. Favus (Eds.).
42. Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 1996, 11:1052-1060.
43. Kovacs C.S., Kronenberg H.M. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 1997, 18:832-872.
44. Cushard W.G., Creditor M.A., Canterbury J.M., Reiss E. Physiologic hyperparathyroidism in pregnancy. J Clin Endocrinol Metab 1972, 34:767-771.
45. Pitkin R.M. Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 1985, 151:99-109.
46. Davis O.K., Hawkins D.S., Rubin L.P., Posillico J.T., Brown E.M., Schiff I. Serum parathyroid hormone (PTH) in pregnant women determined by an immunoradiometric assay for intact PTH. J Clin Endocrinol Metab 1988, 67:850-852.
47. Gertner J.M., Coustan D.R., Kliger A.S., Mallette L.E., Ravin N., Broadus A.E. Pregnancy as a state of physiologic absorptive hypercalciuria. Am J Med 1986, 81:451-456.
48. Rasmussen N., Frolich A., Hornnes P.J., Hegedus L. Serum ionized calcium and intact parathyroid hormone levels during pregnancy and postpartum. Br J Obstet Gynaecol 1990, 97:857-859.
49. Whitehead M., Lane G., Young O., Campbell S., Abeyasekera G., Hillyard C.J., et al. Interrelations of calcium-regulating hormones during normal pregnancy. BMJ 1981, 283:10-12.
50. Frolich A., Rudnicki M., Fischer-Rasmussen W., Olofsson K. Serum concentrations of intact parathyroid hormone during late human pregnancy: a longitudinal study. Eur J Obstet Gynecol Reprod Biol 1991, 42:85-87.
51. Kohlmeier L., Marcus R. Osteoporosis associated with pregnancy. Osteoporosis 1996, 959-967. Academic Press, San Diego. R. Marcus, D. Feldman, J. Kelsey (Eds.).
52. Bertelloni S., Baroncelli G.I., Pelletti A., Battini R., Saggese G. Parathyroid hormone-related protein in healthy pregnant women. Calcif Tissue Int 1994, 54:195-197.
53. Bucht E., Carlqvist M., Hedlund B., Bremme K., Torring O. Parathyroid hormone-related peptide in human milk measured by a mid-molecule radioimmunoassay. Metabolism 1992, 41:11-16.
54. MacIsaac R.J., Heath J.A., Rodda C.P., Moseley J.M., Care A.D., Martin T.J., et al. Role of the fetal parathyroid glands and parathyroid hormone-related protein in the regulation of placenta transport of calcium, magnesium and inorganic phosphate. Reprod Fertil Dev 1991, 3:447-457.
55. Brannon P.M., Picciano M.F. Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr 2011, 31:89-115.
56. Wilson S.G., Retallack R.W., Kent J.C., Worth G.K., Gutteridge D.H. Serum free 1,25-dihydroxyvitamin D and the free 1,25-dihydroxyvitamin D index during a longitudinal study of human pregnancy and lactation. Clin Endocrinol 1990, 32:613-622.
57. Reynolds W.A., Williams G.A., Pitkin R.M. Calciotropic hormone responsiveness during pregnancy. Am J Obstet Gynecol 1981, 139:855-862.
58. Stevenson J.C., Hillyard C.J., MacIntyre I., Cooper H., Whitehead M.I. A physiological role for calcitonin: protection of the maternal skeleton. Lancet 1979, 2:769-770.
59. Bellinger D.C. Teratogen update: lead and pregnancy. Birth Defects Res. (Part A) 2005, 73:409-420.
60. Bellinger D., Leviton A., Waternaux C., Needleman H., Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 1987, 316:1037-1043.
61. Gonzales-Cossfo T., Peterson K.E., Sanin L.H., Fishbein E., Palazuelos E., Aro A., et al. Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics 1997, 100:856-862.
62. Shen X.M., Yan C.H., Guo D., Wu S.M., Li R.Q., Huang H., et al. Low-level prenatal lead exposure and neurobehavioral development of children in the first year of life: a prospective study in Shanghai. Environ Res 1998, 79:1-8.
63. Borja-Aburto V.H., Hertz-Picciotto I., Lopez M.R., Farias P., Rios C., Blanco J. Blood lead levels measured prospectively and risk of spontaneous abortion. Am J Epidemiol 1999, 150:590-597.
64. Rothenberg S.J., Kondrashov V., Manalo M., Jiang J., Cuellar R., Garcia M., et al. Increase in hypertension and blood pressure during pregnancy with increased bone lead levels. Am J Epidemiol 2002, 156:1079-1087.
65. Goyer R.A. Transplacental transport of lead. Environ Health Perspect 1990, 89:101-105.
66. Barry P.S. A comparison of concentrations of lead in human tissues. Br J Ind Med 1975, 32:119-139.
67. Steenhout A. Kinetics of lead storage in teeth and bones: an epidemiologic approach. Arch Environ Health 1982, 37:224-231.
68. Pirkle J.L., Brody D.J., Gunter E.W., Kramer R.A., Paschal D.C., Flegal K.M., et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 1994, 27:284-291.
69. Kaufmann R.B., Clouse T.L., Olson D.R., Matte T.D. Elevated blood lead levels and blood lead screening among US children aged one to five years: 1988-1994. Pediatrics 2000, 106:E79.
70. Brown M.J., Hu H., Gonzales-Cossio T., Peterson K.E., Sanin L.H., de Luz Kageyama M., et al. Determinants of bone and blood lead concentrations in the early postpartum period. Occup Environ Med 2000, 57:535-541.
71. Tellez-Rojo M.M., Hernandez-Avila M., Lamadrid-Figueroa H., Smith D., Hernandez-Cadena L., Mercado A., et al. Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol 2004, 160:668-678.
72. Ettinger A.S., Tellez-Rojo M.M., Amarasiriwardena C., Peterson K.E., Schwartz J., Aro A., et al. Influence of maternal bone lead burden and calcium intake on levels of lead in breast milk over the course of lactation. Am J Epidemiol 2006, 163:48-56.
73. Manton W.I., Angle C.R., Stanek K.L., Kuntzelman D., Rees Y.R., Kuehnemann T.J. Release of lead from bone in pregnancy and lactation. Environ Res 2003, 92:139-151.
74. Lagerkvist B.J., Ekesrydh S., Englyst V., Nordberg G.F., Soderberg H.A., Wiklund D.E. Increased blood lead and decreased calcium levels during pregnancy: a prospective study of Swedish women living near a smelter. Am J Public Health 1996, 86:1247-1252.
75. Hertz-Picciotto I., Schramm M., Watt-Morse M., Chantala K., Anderson J., Osterloh J. Patterns and determinants of blood lead during pregnancy. Am J Epidemiol 2000, 152:829-837.
76. Sowers M., Jannausch M., Scholl T., Li W., Kemp F.W., Bogden J.D. Blood lead concentrations and pregnancy outcomes. Arch Environ Health 2002, 57:489-495.
77. Hernandez-Avila M., Gonzalez-Cossio T., Hernandez-Avila J.E., Romieu I., Peterson K.E., Aro A., et al. Dietary calcium supplements lower blood lead levels in lactating women: a randomized placebo-controlled trial. Epidemiology 2003, 14:206-212.
78. Ettinger A.S., Lamadrid-Figueroa H., Téllez-Rojo M.M., Mercado-García A., Peterson K.E., Schwartz J., et al. Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect 2009, 117:26-31.
79. Sowers M., Wallace R.B., Lemke J.H. Correlates of forearm bone mass among women during maximal bone mineralization. Prev Med 1985, 14:585-596.
80. Sowers M.R., Clark M.K., Hollis B., Wallace R.B., Jannausch M. Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss. J Bone Miner Res 1992, 7:647-657.
81. Fox K.M., Magaziner J., Sherwin R., Scott J.C., Plato C.C., Nevitt M., et al. Reproductive correlates of bone mass in elderly women. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1993, 8:901-908.
82. Cho G.J., Shin J.H., Yi K.W., Park H.T., Kim T., Hur J.Y., et al. Adolescent pregnancy is associated with osteoporosis in postmenopausal women. Menopause 2012, 19:456-460.
83. Schnatz P.F., Barker K.G., Marakovits K.A., O'Sullivan D.M. Effects of age at first pregnancy and breast-feeding on the development of postmenopausal osteoporosis. Menopause 2010, 17:1161-1166.
84. Smith R.W. Dietary and hormonal factors in bone loss. Fed Proc 1967, 26:1737-1746.
85. Nilsson B.E. Parity and osteoporosis. Surg Gynecol Obstet 1969, 129:27-28.
86. Melton L.J., Bryant S.C., Wahner H.W., O'Fallon W.M., Malkasian G.D., Judd H.L., et al. Influence of breastfeeding and other reproductive factors on bone mass later in life. Osteoporos Int 1993, 3:76-83.
87. Laitinen K., Valimaki M., Keto P. Bone mineral density measured by dual-energy x-ray absorptiometry in healthy Finnish women. Calcif Tissue Int 1991, 48:224-231.
88. Cox M.L., Khan S.A., Gau D.W., Cox S.A., Hodkinson H.M. Determinants of forearm bone density in premenopausal women: a study in one general practice. Br J Gen Pract 1991, 41:194-196.
89. Picard D., Ste-Marie L.G., Coutu D., Carrier L., Chartrand R., Lepage R., et al. Premenopausal bone mineral content relates to height, weight and calcium intake during early adulthood. Bone Miner 1988, 4:299-309.
90. Walker A.R., Richardson B., Walker F. The influence of numerous pregnancies and lactations on bone dimensions in South African Bantu and Caucasian mothers. Clin Sci 1972, 42:189-196.
91. Hreshchyshyn M.M., Hopkins A., Zylstra S., Anbar M. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 1988, 159:318-322.
92. Stevenson J.C., Lees B., Devenport M., Cust M.P., Ganger K.F. Determinants of bone density in normal women: risk factors for future osteoporosis?. BMJ 1989, 298:924-928.
93. Bauer D.C., Browner W.S., Cauley J.A., Orwoll E.S., Scott J.C., Black D.M., et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993, 118:657-665.
94. Kritz-Silverstein D., Barrett-Connor E., Hollenbach K.A. Pregnancy and lactation as determinants of bone mineral density in postmenopausal women. Am J Epidemiol 1992, 136:1052-1059.
95. Henderson P.H., Sowers M., Kutzko K.E., Jannausch M.L. Bone mineral density in grand multiparous women with extended lactation. Am J Obstet Gynecol 2000, 182:1371-1377.
96. Allali F., Maaroufi H., Aichaoui S.E., Khazani H., Saoud B., Benyahya B., et al. Influence of parity on bone mineral density and peripheral fracture risk in Moroccan postmenopausal women. Maturitas 2007, 57:392-398.
97. Lenora J., Lekamwasam S., Karlsson M.K. Effects of multiparity and prolonged breast-feeding on maternal bone mineral density: a community-based cross-sectional study. BMC Womens Health 2009, 9:19.
98. Turan V. Grand-grand multiparity (more than 10 deliveries) does not convey a risk for osteoporosis. Acta Obstet Gynecol Scand 2011, 90:1440-1442.
99. Petersen H.C., Jeune B., Vaupel J.W., Christensen K. Reproduction life history and hip fractures. Ann Epidemiol 2002, 12:257-263.
100. Paganini-Hill A., Chao A., Ross R.K., Henderson B.E. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 1991, 2:16-25.
101. Hoffman S., Grisso J.A., Kelsey J.L., Gammon M.D., O'Brien L.A. Parity, lactation and hip fracture. Osteoporos Int 1993, 3:171-176.
102. Michaelsson K., Baron J.A., Farahmand B.Y., Ljunghall S. Influence of parity and lactation on hip fracture risk. Am J Epidemiol 2001, 153:1166-1172.
103. Kreiger N., Kelsey J.L., Holford T.R., O'Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 1982, 116:141-148.
104. Kreiger N., Gross A., Hunter G. Dietary factors and fracture in postmenopausal women: a case-control study. Int J Epidemiol 1992, 21:953-958.
105. Alderman B.W., Weiss N.S., Daling J.R., Ure C.L., Ballard J.H. Reproductive history and postmenopausal risk of hip and forearm fracture. Am J Epidemiol 1986, 124:262-267.
106. Cumming R.G., Klineberg R.J. Breastfeeding and other reproductive factors and the risk of hip fractures in elderly women. Int J Epidemiol 1993, 22:684-691.
107. Laskey M.A., Prentice A., Shaw J., Zachou T., Ceesay S.M., Vasquez-Velasquez L., et al. Breast-milk calcium concentrations during prolonged lactation in British and rural Gambian mothers. Acta Paediatr Scand 1990, 79:507-512.
108. Thomas M.L. Calcium uptake by duodenal epithelial cells is increased during lactation. Proc Soc Exp Biol Med 1991, 196:214-217.
109. Kent G.N., Price R.I., Gutteridge D.H., Rosman K.J., Smith M., Allen J.R., et al. The efficiency of intestinal calcium absorption is increased in late pregnancy but not in established lactation. Calcif Tissue Int 1991, 48:293-295.
110. Specker B.L., Vieira N.E., O'Brien K.O., Ho M.L., Heubi J.E., Abrams S.A., et al. Calcium kinetics in lactating women with low and high calcium intakes. Am J Clin Nutr 1994, 59:593-599.
111. Baird D.T., McNeilly A.S., Sawers R.S., Sharpe R.M. Failure of estrogen-induced discharge of luteinizing hormone in lactating women. J Clin Endocrinol Metab 1979, 49:500-506.
112. Zarate A., Canales E.S. Endocrine aspects of lactation and postpartum infertility. J Steroid Biochem 1987, 27:1023-1028.
113. Schlechte J.A., Sherman B., Martin R. Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab 1983, 56:1120-1123.
114. Klibanski A., Neer R.M., Beitins I.Z., Ridgway E.C., Zervas N.T., McArthur J.W. Decreased bone density in hyperprolactinemic women. N Engl J Med 1980, 303:1511-1514.
115. Kalkwarf H.J., Specker B.L., Bianchi D.C., Ranz J., Ho M. The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 1997, 337:523-528.
116. Kent G.N., Price R.I., Gutteridge D.H., Smith M., Allen J.R., Bhagat C.I., et al. Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaning. J Bone Miner Res 1990, 5:361-369.
117. Sowers M., Corton G., Shapiro B., Jannausch M.L., Crutchfield M., Smith M.L., et al. Changes in bone density with lactation. JAMA 1993, 269:3130-3135.
118. Specker B.L., Tsang R.C., Ho M.L. Changes in calcium homeostasis over the first year postpartum: effect of lactation and weaning. Obstet Gynecol 1991, 78:56-62.
119. Lees C.J., Jerome C.P., Register T.C., Carlson C.S. Changes in bone mass and bone biomarkers of cynomolgus monkeys during pregnancy and lactation. J Clin Endocrinol Metab 1998, 83:4298-4302.
120. Sowers M.F., Hollis B.W., Shapiro B., Randolph J., Janney C.A., Zhang D., et al. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 1996, 276:549-554.
121. Sowers M., Randolph J., Shapiro B., Jannausch M. A prospective study of bone density and pregnancy after an extended period of lactation with bone loss. Obstet Gynecol 1995, 85:285-289.
122. Prentice A., Jarjou L.M., Stirling D.M., Buffenstein R., Fairweather-Tait S. Biochemical markers of calcium and bone metabolism during 18 months of lactation in Gambian women accustomed to a low calcium intake and in those consuming a calcium supplement. J Clin Endocrinol Metab 1998, 83:1059-1066.
123. Little K.D., Clapp J.F. Self-selected recreational exercise has no impact on early postpartum lactation-induced bone loss. Med Sci Sports Exerc 1998, 30:831-836.
124. Lovelady C.A., Bopp M.J., Colleran H.L., Mackie H.K., Wideman L. Effect of exercise training on loss of bone mineral density during lactation. Med Sci Sports Exerc 2009, 41:1902-1907.
125. Caird L.E., Reid-Thomas V., Hannan W.J., Gow S., Glasier A.F. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women. Clin Endocrinol 1994, 41:739-745.
126. Brommage R., DeLuca H.F. Regulation of bone mineral loss during lactation. Am J Physiol 1985, 248:E182-E187.
127. Garner S.C., Boass A., Toverud S.U. Parathyroid hormone is not required for normal milk consumption or secretion or lactation-associated bone loss in normocalcemic rats. J Bone Miner Res 1990, 5:69-75.
128. Greer F.R., Tsang R.C., Searcy J.E., Levin R.S., Steichen J.J. Mineral homeostasis during lactation relationship to serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone and calcitonin. Am J Clin Nutr 1982, 36:431-437.
129. Carneiro R.M., Prebehalla L., Tedesco M.B., Sereika S.M., Hugo M., Hollis B.W., et al. Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover. J Clin Endocrinol Metab 2010, 95:1767-1776.
130. Ardeshirpour L., Dann P., Adams D.J., Nelson T., VanHouten J., Horowitz M.C., et al. Weaning triggers a decrease in receptor activator of nuclear factor-kappaB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice. Endocrinology 2007, 148:3875-3886.
131. Sowers M., Zhang D., Hollis B.W., Shapiro B., Janney C.A., Crutchfield M., et al. Role of calciotrophic hormones in calcium mobilization of lactation. Am J Clin Nutr 1998, 67:284-291.
132. Broadus A.E., Mangin M., Ikeda K., Isogna K.L., Weir E.C., Burtis W.J., et al. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med 1988, 319:556-563.
133. Wada S., Kitamura H., Matsuura Y., Katayama Y., Ohkawa H., Kugai N., et al. Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma. Intern Med 1992, 31:968-972.
134. Vargas S.J.M., Gillespie T., Powell G.J., Southby J., Danks J.A., Moseley J.M., et al. Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 1992, 7:971-979.
135. Ratcliffe W.A., Thompson G.E., Care A.D., Peaker M. Production of parathyroid hormone-related protein by the mammary gland of the goat. J Endocrinol 1992, 133:87-93.
136. Thiede M.A., Rodan G.A. Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science 1988, 242:278-280.
137. Thiede M.A. The mRNA encoding a parathyroid hormone-like peptide is produced in mammary tissue in response to elevations in serum prolactin. Mol Endocrinol 1989, 3:1443-1447.
138. Budayr A.A., Halloran B.P., King J.C., Diep D., Nissenson R.A., Strewler G.J. High levels of a parathyroid hormone-like protein in milk. Proc Natl Acad Sci U S A 1989, 86:7183-7185.
139. Law F.M., Moate P.J., Leaver D.D., Diefenbach-Jagger H., Grill V., Ho P.W., et al. Parathyroid hormone-related protein in milk and its correlation with bovine milk calcium. J Endocrinol 1991, 128:21-26.
140. Ardeshirpour L., Dann P., Pollak M., Wysolmerski J., VanHouten J. The calcium-sensing receptor regulates PTHrP production and calcium transport in the lactating mammary gland. Bone 2006, 38:787-793.
141. Kirby B.J., Ardeshirpour L., Woodrow J.P., Wysolmerski J.J., Sims N.A., Karaplis A.C., et al. Skeletal recovery after weaning does not require PTHrP. J Bone Miner Res 2011, 26:1242-1251.
142. Stiegler C., Leb G., Kleinert R., Warnkross H., Ramschak-Schwarzer S., Lipp R., et al. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status. J Bone Miner Res 1995, 10:751-759.
143. Canalis E., McCarthy T.L., Centrella M. Differential effects of continuous and transient treatment with parathyroid hormone related peptide (PTHrp) on bone collagen synthesis. Endocrinology 1990, 126:1806-1812.
144. Uzawa T., Hori M., Ejiri S., Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone. Bone 1995, 16:477-484.
145. Ribot C., Tremollieres F., Pouilles J.M., Albarede J.L., Mansat M., Utheza G., et al. Risk factors for hip fracture. MEDOS study: results of the Toulouse Center. Bone 1993, 14(Suppl):S77-S80.
146. Bjornerem A., Ahmed L.A., Jorgensen L., Stormer J., Joakimsen R.M. Breastfeeding protects against hip fracture in postmenopausal women: the Tromso study. J Bone Miner Res 2011, 26:2843-2850.
147. Sowers M., Eyre D., Hollis B.W., Randolph J.F., Shapiro B., Jannausch M.L., et al. Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab 1995, 80:2210-2216.
148. Holmberg-Marttila D., Leino A., Sievanen H. Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses. Osteoporos Int 2003, 14:103-109.
149. Vihko R., Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem 1984, 20:231-236.
150. Grumbach M., Grave G.D., Mayer F. Control of the Onset of Puberty 1974, Wiley, New York.
151. Frisch R.E., Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 1970, 169:397-399.
152. Frisch R.E., McArthur J.W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974, 185:949-951.
153. Nimrod A., Ryan K.J. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab 1975, 40:367-372.
154. Scott E.C., Johnston F.E. Critical fat, menarche, and the maintenance of menstrual cycles: a critical review. J Adolesc Health Care 1982, 2:249-260.
155. Guo Y., Zhao L.J., Shen H., Guo Y., Deng H.W. Genetic and environmental correlations between age at menarche and bone mineral density at different skeletal sites. Calcif Tissue Int 2005, 77:356-360.
156. Garn S.M., LaVelle M., Rosenberg K.R., Hawthorne V.M. Maturational timing as a factor in female fatness and obesity. Am J Clin Nutr 1986, 43:879-883.
157. Galuska D.A., Sowers M.F. Predictors of Bone Density in Nulliparous, Young Women: The Role of Age of Menarche and Body Composition 1995, Doctoral dissertation, University Microfilms, Ann Arbor, MI.
158. Rosenthal D.I., Mayo-Smith W., Hayes C.W., Khurana J.S., Biller B.M., Neer R.M., et al. Age and bone mass in premenopausal women. J Bone Miner Res 1989, 4:533-538.
159. Georgiou E., Ntalles K., Papageorgiou A., Korkotsidis A., Proukakis C. Bone mineral loss related to menstrual history. Acta Orthop Scand 1989, 60:192-194.
160. Nicodemus K.K., Folsom A.R., Anderson K.E. Menstrual history and risk of hip fractures in postmenopausal women. The Iowa Women's Health Study. Am J Epidemiol 2001, 153:251-255.
161. Hesdorffer D.C., Melton L.J., Malkasian G.D., Atkinson E.J., Brinton L.A., O'Fallon W.M. Hip fractures among infertile women. Am J Epidemiol 1999, 149:810-813.
162. Prior J.C., Vigna Y.M., Schechter M.T., Burgess A.E. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990, 323:1221-1227.
163. Sowers M.R., Shapiro B., Gilbraith M.A., Jannausch M. Health and hormonal characteristics of premenopausal women with lower bone mass. Calcif Tissue Int 1990, 47:130-135.
164. Sowers M., Randolph J.F., Crutchfield M., Jannausch M.L., Shapiro B., Zhang B., et al. Urinary ovarian and gonadotrophin hormone levels in premenopausal women with low bone mass. J Bone Miner Res 1998, 13:1191-1202.
165. Steinberg K.K., Freni-Titulaer L.W., DePuey E.G., Miller D.T., Sgoutas D.S., Coralli C.H., et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 1989, 69:533-539.
166. Grewal J., Sowers M.R., Randolph J.F., Harlow S.D., Lin X. Low bone mineral density in the early menopausal transition: role for ovulatory function. J Clin Endocrinol Metab 2006, 91:3780-3785.
167. Baker E., Demers L. Menstrual status in female athletes: correlation with reproductive hormones and bone density. Obstet Gynecol 1988, 72:683-687.
168. Cann C.E., Martin M.C., Genant H.K., Jaffe R.B. Decreased spinal mineral content in amenorrheic women. JAMA 1984, 251:626-629.
169. Drinkwater B.L., Nilson K., Chesnut C.H., Bremner W.J., Shainholtz S., Southworth M.B. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med 1984, 311:277-281.
170. Drinkwater B.L., Nilson K., Ott S., Chesnut C.H. Bone mineral density after resumption of menses in amenorrheic athletes. JAMA 1986, 256:380-382.
171. Feicht C.B., Johnson T.S., Martin B.J., Sparkes K.E., Wagner W.W. Secondary amenorrhea in athletes. Lancet 1978, 2:1145-1146.
172. Lindberg J.S., Fears W.B., Hunt M.M., Powell M.R., Boll D., Wade C.E. Exercise-induced amenorrhea and bone density. Ann Intern Med 1984, 101:647-648.
173. Linnell S.L., Stager J.M., Blue P.W., Oyster N., Robertshaw D. Bone mineral content and menstrual regularity in female runners. Med Sci Sports Exerc 1984, 16:343-348.
174. Marcus R., Cann C., Madvig P., Minkoff J., Goddard M., Bayer M., et al. Menstrual function and bone mass in elite women distance runners. Endocrine and metabolic features. Ann Intern Med 1985, 102:158-163.
175. Warren M.P., Brooks-Gunn J., Hamilton L.H., Warren L.F., Hamilton W.G. Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea. N Engl J Med 1986, 314:1348-1353.
176. Kaga M., Takahashi K., Ishihara T., Suzuki H., Tanaka H., Seino Y., et al. Bone assessment of female long-distance runners. J Bone Miner Metab 2004, 22:509-513.
177. Mora S., Prinster C., Proverbio M.C., Bellini A., De Poli S.C.L., Weber G., et al. Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Calcif Tissue Int 1998, 63:369-374.
178. Blumsohn A., Hannon R.A., Wrate R., Barton J., al-Dehaimi A.W., Colwell A., et al. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol 1994, 40:663-670.
179. Nelson M.E., Fisher E.C., Catsos P.D., Meredith C.N., Turksoy R.N., Evans W.J. Diet and bone status in amenorrheic runners. Am J Clin Nutr 1986, 43:910-916.
180. Drinkwater B.L., Bruemner B., Chesnut C.H. Menstrual history as a determinant of current bone density in young athletes. JAMA 1990, 263:545-548.
181. Henley K., Vaitukaitis J.L. Exercise-induced menstrual dysfunction. Annu Rev Med 1988, 39:443-451.
182. Lloyd T., Myers C., Buchanan J.R., Demers L.M. Collegiate women athletes with irregular menses during adolescence have decreased bone density. Obstet Gynecol 1988, 72:639-642.
183. Ding J.H., Sheckter C.B., Drinkwater B.L., Soules M.R., Bremner W.J. High serum cortisol levels in exercise-associated amenorrhea. Ann Intern Med 1988, 108:530-534.
184. Shangold M.M., Gatz M.L., Thysen B. Acute effect of exercise on plasma concentrations of prolactin and testosterone in recreational women runners. Fertil Steril 1981, 35:699-702.
185. Chang F.E., Dodds W.G., Sullivan M., Kim M.H., Malarkey W.B. The acute effects of exercise on prolactin and growth hormone secretion: comparison between sedentary women and women runners with normal and abnormal menstrual cycles. J Clin Endocrinol Metab 1986, 62:551-556.
186. Jurkowski J.E., Jones N.L., Walker C., Younglai E.V., Sutton J.R. Ovarian hormonal response to exercise. J Appl Physiol 1978, 44:109-114.
187. Brisson G.R., Volle M.A., DeCarufel D., Desharnais M., Tanaka M. Exercise-induced disassociation of the blood prolactin response in young women according to their sports habits. Horm Metab Res 1980, 12:201-205.
188. Dale E., Gerlach D.H., Wilhite A.L. Menstrual dysfunction in distance runners. Obstet Gynecol 1979, 54:47-53.
189. Frisch R.E. Body fat, menarche, fitness and fertility. Hum Reprod 1987, 2:521-533.
190. Myburgh K.H., Bachrach L.K., Lewis B., Kent K., Marcus R. Low bone mineral density at axial and appendicular sites in amenorrheic athletes. Med Sci Sports Exerc 1993, 25:1197-1202.
191. Barrack M.T., Rauh M.J., Nichols J.F. Prevalence of and traits associated with low BMD among female adolescent runners. Med Sci Sports Exerc 2008, 40:2015-2021.
192. Kelly P.J., Eisman J.A., Stuart M.C., Pocock N.A., Sambrook P.N., Gwinn T.H. Somatomedin-C, physical fitness, and bone density. J Clin Endocrinol Metab 1990, 70:718-723.
193. Ayers J.W., Gidwani G.P., Schmidt I.M., Gross M. Osteopenia in hypoestrogenic young women with anorexia nervosa. Fertil Steril 1984, 41:224-228.
194. Biller B.M., Saxe V., Herzog D.B., Rosenthal D.I., Holzman S., Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989, 68:548-554.
195. Rigotti N.A., Nussbaum S.R., Herzog D.B., Neer R.M. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984, 311:1601-1606.
196. Kumar K.K., Tung S., Iqbal J. Bone loss in anorexia nervosa: leptin, serotonin, and the sympathetic nervous system. Ann N Y Acad Sci 2010, 1211:51-65.
197. Bachrach L.K., Guido D., Katzman D., Litt I.F., Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990, 86:440-447.
198. Myerson M., Gutin B., Warren M.P., Wang J., Lichtman S., Pierson R., et al. Total body bone density in amenorrheic runners. Obstet Gynecol 1992, 79:973-978.
199. Raymond C.A. Long-term sequelae pondered in anorexia nervosa. JAMA 1987, 257:3324-3325.
200. Vestergaard P., Emborg C., Stoving R.K., Hagen C., Mosekilde L., Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders a nationwide register study. Int J Eat Disord 2002, 32:301-308.
201. Klibanski A., Greenspan S.L. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 1986, 315:542-546.
202. Schlechte J., Walkner L., Kathol M. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. J Clin Endocrinol Metab 1992, 75:698-703.
203. Klibanski A., Biller B.M., Rosenthal D.I., Schoenfeld D.A., Saxe V. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 1988, 67:124-130.
204. Shibli-Rahhal A., Schlechte J. The effects of hyperprolactinemia on bone and fat. Pituitary 2009, 12:96-104.
205. Di Carlo C., Shoham Z., MacDougall J., Patel A., Hall M.L., Jacobs H.S. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril 1992, 57:314-319.
206. Kassanos D., Trakakis E., Baltas C.S., Papakonstantinou O., Simeonidis G., Salamalekis G., et al. Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study. Hum Reprod 2010, 25:2107-2114.
207. Goldsmith N.F., Johnston J.O. Bone mineral: effects of contraceptives, pregnancy and lactation. J Bone Joint Surg 1975, 57-A:657-668.
208. Lindsay R., Tohme J., Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception 1986, 34:333-340.
209. Seeman E., Szmukler G.I., Formica C., Tsalamandris C., Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 1992, 7:1467-1474.
210. Enzelsberger H., Metka M., Heytmanek G., Schurz B., Kurz C., Kusztrich M. Influence of oral contraceptive use on bone density in climacteric women. Maturitas 1988, 9:375-378.
211. Armamento-Villareal R., Villareal D.T., Avioli L.V., Civitelli R. Estrogen status and heredity are major determinants of premenopausal bone mass. J Clin Invest 1992, 90:2464-2471.
212. Kleerekoper M., Brienza R.S., Schultz L.R., Johnson C.C. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch Intern Med 1991, 151:1971-1976.
213. Kritz-Silverstein D., Barrett-Connor E. Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Am. J. Public Health 1993, 83:100-102.
214. Lloyd T., Buchanan J.R., Ursino G.R., Myers C., Woodward G., Halbert D.R. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol 1989, 160:402-404.
215. Murphy S., Khaw K.T., Compston J.E. Lack of relationship between hip and spine bone mineral density and oral contraceptive use. Eur J Clin Invest 1993, 23:108-111.
216. Fortney J.A., Feldblum P.J., Talmage R.V., Zhang J., Godwin S.E. Bone mineral density and history of oral contraceptive use. J Reprod Med 1994, 39:105-109.
217. Berning B., van Kuijk C., Schutte H.E., Kuiper J.W., Drogendijk A.C., Fauser B.C. Determinants of lumbar bone mineral density in normal weight, non-smoking women soon after menopause. A study using clinical data and quantitative computed tomography. Bone Miner 1993, 21:129-139.
218. Recker R.R., Davies K.M., Hinders S.M., Heaney R.P., Stegman M.R., Kimmel D. B. Bone gain in young adult women. JAMA 1992, 268:2403-2408.
219. Mais V., Fruzzetti F., Ajossa S., Paoletti A.M., Guerriero S., Melis G.B. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinyl estradiol: a prospective study. Contraception 1993, 48:445-452.
220. Gambacciani M., Spinetti A., Taponeco F., Cappagli B., Piaggesi L., Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol 1994, 83:392-396.
221. Garnero P., Sornay-Rendu E., Delmas P.D. Decreased bone turnover in oral contraceptive users. Bone 1995, 16:499-503.
222. Michaelsson K., Baron J.A., Farahmand B.Y., Persson I., Ljunghall S. Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet 1999, 353:1481-1484.
223. Cooper C., Hannaford P., Croft P., Kay C.R. Oral contraceptive pill use and fractures in women: a prospective study. Bone 1993, 14:41-45.
224. Barad D., Kooperberg C., Wactawski-Wende J., Liu J., Hendrix S.L., Watts N.B. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study. Fertil Steril 2005, 84:374-383.
225. Lopez L.M., Grimes D.A., Schulz K.F., Curtis K.M. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst. Rev. 2011, (7). CD006033.
226. Cundy T., Evans M., Roberts H., Wattie D., Ames R., Reid I.R. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ 1991, 303:13-16.
227. Cundy T., Cornish J., Roberts H., Elder H., Reid I.R. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 1998, 92:569-573.
228. Cundy T., Cornish J., Evans M.C., Roberts H., Reid I.R. Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ 1994, 308:247-248.
229. Gbolade B., Elllis S., Murby B., Randall S., Kirkman R. Bone density in long term users of depot medroxyprogesterone acetate. Br J Obstet Gynaecol 1998, 105:790-794.
230. Clark M.K., Sowers M.R., Nichols S., Levy B. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2004, 82:1580-1586.
231. Cromer B.A., Blair J.M., Mahan J.D., Zibners L., Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996, 129:671-676.
232. Berenson A.B., Radecki C.M., Grady J.J., Rickert V.I., Thomas A. A prospective controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001, 98:576-582.
233. Scholes D., LaCroix A.Z., Ichikawa L.E., Barlow W.E., Ott S.M. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002, 13:581-587.
234. Tang O.S., Tang G., Yip P.S., Li B. Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study. Contraception 2000, 62:161-164.
235. Merki-Feld G.S., Neff M., Keller P.J. A prospective study on the effects of depot medroxyprogesterone acetate on trabecular and cortical bone after attainment of peak bone mass. BJOG 2000, 107:863-869.
236. Ott S.M., Scholes D., Lacroix A.Z., Ichikawa L.E., Yoshida C.K., Barlow W.E. Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab 2001, 86:179-185.
237. Clark M.K., Sowers M., Levy B., Nichols S. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2006, 86:1466-1477.
238. Harel Z., Johnson C.C., Gold M.A., Cromer B., Peterson E., Burkman R., et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010, 81:281-291.
239. Canterbury C., Hatcher R. Serum estradiol levels in women using Depo-Provera for more than a year 1997, Proceedings from the Contraceptive Technology Conference, Washington, DC, 68-79.
240. Speroff L., Glass R.H., Kase N.G. Clinical Gynecologic Endocrinology and Infertility 1994, Williams and Wilkins, Baltimore. 5th ed.
241. Clark M.K., Sowers M., Levy B.T., Tenhundfeld P. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception. Fertil Steril 2001, 75:871-877.
242. Mishell D.R., Kharma K.M., Thorneycroft I.H., Nakamura R.M. Estrogenic activity in women receiving an injectable progestogen for contraception. Am J Obstet Gynecol 1972, 113:372-376.
243. Belsey E.M. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 1988, 38:181-206.
244. Ortiz A., Hirol M., Stanczyk F.Z., Goebelsmann U., Mishell D.R. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J Clin Endocrinol Metab 1977, 44:32-38.
245. Sangi-Haghpeykar H., Poindexter A.N., Bateman L., Ditmore J.R. Experiences of injectable contraceptive users in an urban setting. Obstet Gynecol 1996, 88:227-233.
246. Schwallie P.C., Assenzo J.R. Contraceptive use-efficiency study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril 1973, 24:331-339.
247. Rome E., Ziegler J., Secic M., Bonny A., Stager M., Lazebnik R., et al. Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive. J Pediatr Adolesc Gynecol 2004, 17:373-377.
248. Cromer B.A., Lazebnik R., Rome E., Stager M., Bonny A., Ziegler J., et al. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. Am J Obstet Gynecol 2005, 192:42-47.
249. Johnston C.C., Miller J.Z., Slemenda C.W., Reister T.K., Hui S., Christian J.C., et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992, 327:82-87.
250. Nieves J.W., Golden A.L., Siris E., Kelsey J.L., Lindsay R. Teenage and current calcium intake are related to bone mineral density of the hip and forearm in women aged 30-39 years. Am J Epidemiol 1995, 15:342-351.
251. Kristinsson J.O., Valdimarsson O., Steingrimsdottir L., Sigurdsson G. Relation between calcium intake, grip strength and bone mineral density in the forearms of girls aged 13 and 15. J Intern Med 1994, 236:385-390.
252. Valimaki M.J., Karkkainen M., Lamberg-Allardt C., Laitinen K., Alhava E., Heikkinen J., et al. Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular Risk in Young Finns Study Group. BMJ 1994, 309:230-235.
253. Rees H.D., Bonsall R.W., Michael R.P. Localization of the synthetic progestin 3H-ORG 2058 in neurons of the primate brain: evidence for the site of action of progestins on behavior. J Comp Neurol 1985, 235:336-342.
254. Rodin A., Murby B., Smith M.A., Caleffi Fentiman M.I., Chapman M.G., et al. Premenopausal bone loss in lumbar spine and neck of femur: a study of 225 Caucasian women. Bone 1990, 11:1-5.
255. Samojlik E., Kirschner M.A., Silber D., Schneider G., Ertel N.H. Elevated production and metabolic clearance rates of androgens in morbidly obese women. J Clin Endocrinol Metab 1984, 59:949-954.
256. Siiteri P.K. Adipose tissue as a source of hormones. Am J Clin Nutr 1987, 45(1 Suppl):277-282.
257. Fraser I.S., Weisberg E. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Aust 1981, 1(Suppl 1):3-19.
258. el-Mahgoub S. Body weight and cycle control of injectable contraceptives. J Reprod Med 1980, 24:119-126.
259. Leiman G. Depo-medroxyprogesterone acetate as a contraceptive agent: its effect on weight and blood pressure. Am J Obstet Gynecol 1972, 114:97-102.
260. Mukherjea M., Mukherjee P., Biswas R. Long-term contraception with Depo-Provera: a clinical evaluation. Int J Fertil 1980, 25:122-126.
261. Moore L.L., Valuck R., McDougall C., Fink W. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives. Contraception 1995, 52:215-219.
262. Mainwaring R., Hales H.A., Stevenson K., Hatasaka H.H., Poulson A.M., Jones K.P., et al. Metabolic parameters, bleeding, and weight changes in U.S. women using progestin only contraceptives. Contraception 1995, 51:149-153.
263. Clark M.K., Dillon J.S., Sowers M., Nichols S. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes 2005, 29:1252-1258.
264. Meier C., Brauchli Y.B., Jick S.S., Kraenzlin M.E., Meier C.R. Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrinol Metab 2010, 95:4909-4916.
265. Gallagher J.C., Young M.M., Nordin B.E. Effects of artificial menopause on plasma and urine calcium and phosphate. Clin Endocrinol 1972, 1:57-64.
266. Richelson L.S., Wahner H.W., Melton L.J., Riggs B.L. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984, 311:1273-1275.
267. Aitken J.M., Hart D.M., Lindsay R., Anderson J.B., Smith D.A., Wilson G.M. Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy. Isr J Med Sci 1976, 12:607-614.
268. Meema S., Meema H.E. Evaluation of cortical bone mass, thickness and density by z-scores in osteopenic conditions and in relation to menopause and estrogen treatment. Skeletal Radiol 1982, 8:259-268.
269. Svanberg L. Effects of estrogen deficiency in women castrated when young. Acta Obstet Gynecol Scand Suppl 1981, 106:11-15.
270. Ohta H., Makita K., Suda Y., Ikeda T., Masuzawa T., Nozawa S. Influence of oophorectomy on serum levels of sex steroids and bone metabolism and assessment of bone mineral density in lumbar trabecular bone by QCT-C value. J Bone Miner Res 1992, 7:659-665.
271. Ohta H., Masuzawa T., Ikeda T., Suda Y., Makita K., Nozawa S. Which is more osteoporosis-inducing, menopause or oophorectomy?. Bone Miner 1992, 19:273-285.
272. Yoshida T., Takahashi K., Yamatani H., Takata K., Kurachi H. Impact of surgical menopause on lipid and bone metabolism. Climacteric 2011, 14:445-452.
273. Stepan J.J., Pospichal J., Presl J., Pacovsky V. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone 1987, 8:279-284.
274. Reeve J. Bone turnover and trabecular plate survival after artificial menopause. BMJ (Clin Res Ed) 1987, 295:757-760.
275. Genant H.K., Cann C.E., Ettinger B., Gordan G.S. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982, 97:699-705.
276. Hreshchyshyn M.M., Hopkins A., Zylstra S., Anbar M. Effects of natural menopause, hysterectomy, and oophorectomy on lumbar spine and femoral neck bone densities. Obstet Gynecol 1988, 72:631-638.
277. Melton L.J., Crowson C.S., Malkasian G.D., O'Fallon W.M. Fracture risk following bilateral oophorectomy. J Clin Epidemiol 1996, 49:1111-1115.
278. Lindsay R., Hart D.M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 1980, 2:1151-1154.
279. Gambacciani M., Spinetti A., Cappagli B., Taponeco F., Felipetto R., Parrini D., et al. Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women. J Endocrinol Invest 1993, 16:333-337.
280. Mazzuoli G.F., Tabolli S., Bigi F., Valtorta C., Minisola S., Diaciniti D., et al. Effects of salmon calcitonin on the bone loss induced by ovariectomy. Calcif Tissue Int 1990, 47:209-214.